LAT1 (SLC7A5) Overexpression in Negative Her2 Group of Breast Cancer: A Potential Therapy Target.
Khaldon BodoorRowida AlmomaniMohammad Abdulhameed Al-QudahYazan HaddadWalaa SamouriPublished in: Asian Pacific journal of cancer prevention : APJCP (2020)
Our findings of overexpression of LAT1 in negative HER2 group suggest a role of this protein as prognosticator and drug target in a challenging therapeutic cohort.<br />.